Top compounds associated with response to RAD9A


Feature Type Standardized
Nominal ANOVA
mRNA GSK2126458 GDSC1000 pan-cancer AAC 0.097 0.005
mRNA KIN001-102 GDSC1000 pan-cancer AAC 0.09 0.005
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.11 0.005
mRNA Axitinib CTRPv2 pan-cancer AAC -0.098 0.006
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.11 0.006
mRNA Pazopanib GDSC1000 pan-cancer AAC -0.1 0.006
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.094 0.007
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.007
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.008
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC 0.098 0.009
Download CSV